NO854730L - Mellomprodukter for bruk ved fremstilling av antibakterielt virksomme cefem-forbindelser og fremgangsmaate for deres fremstilling - Google Patents
Mellomprodukter for bruk ved fremstilling av antibakterielt virksomme cefem-forbindelser og fremgangsmaate for deres fremstillingInfo
- Publication number
- NO854730L NO854730L NO854730A NO854730A NO854730L NO 854730 L NO854730 L NO 854730L NO 854730 A NO854730 A NO 854730A NO 854730 A NO854730 A NO 854730A NO 854730 L NO854730 L NO 854730L
- Authority
- NO
- Norway
- Prior art keywords
- intermediates
- procedure
- manufacture
- preparation
- antibacterial effective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1984/000212 WO1985004879A1 (fr) | 1984-04-23 | 1984-04-23 | Nouveaux composes de cephem |
| PCT/JP1984/000270 WO1985005620A1 (en) | 1984-05-25 | 1984-05-25 | Cephem compounds |
| PCT/JP1985/000102 WO1986005184A1 (en) | 1985-03-01 | 1985-03-01 | Antibacterial compound |
| NO851538A NO165842C (no) | 1984-04-23 | 1985-04-17 | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO854730L true NO854730L (no) | 1985-10-24 |
| NO167293B NO167293B (no) | 1991-07-15 |
| NO167293C NO167293C (no) | 1991-10-23 |
Family
ID=27304399
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO851538A NO165842C (no) | 1984-04-23 | 1985-04-17 | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. |
| NO85854730A NO167293C (no) | 1984-04-23 | 1985-11-26 | Mellomprodukter. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO851538A NO165842C (no) | 1984-04-23 | 1985-04-17 | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0160252B1 (no) |
| JP (1) | JPH07103130B2 (no) |
| KR (2) | KR920008945B1 (no) |
| AU (1) | AU580995B2 (no) |
| CA (1) | CA1283096C (no) |
| DE (2) | DE3586547D1 (no) |
| ES (4) | ES8606362A1 (no) |
| FI (1) | FI851592L (no) |
| GR (1) | GR850965B (no) |
| NO (2) | NO165842C (no) |
| NZ (1) | NZ211858A (no) |
| PH (1) | PH23134A (no) |
| PT (1) | PT80328B (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH22107A (en) * | 1984-06-07 | 1988-06-01 | Takeda Chemical Industries Ltd | 3-pyrazolo(1,5-a)pyrdinium cephem compounds |
| DE3688477T2 (de) * | 1985-03-01 | 1993-09-16 | Takeda Chemical Industries Ltd | Antibakterielle verbindungen, ihre herstellung und verwendung. |
| ATE89826T1 (de) * | 1985-03-01 | 1993-06-15 | Takeda Chemical Industries Ltd | Antibakterielle verbindungen, ihre herstellung und verwendung. |
| JP2519054B2 (ja) * | 1986-06-09 | 1996-07-31 | 武田薬品工業株式会社 | 新規セフェム化合物 |
| US4921851A (en) * | 1986-06-09 | 1990-05-01 | Takeda Chemical Industries, Ltd. | Cephem compounds, their production and use |
| DE3707019A1 (de) * | 1987-03-05 | 1988-09-15 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
| US4933334A (en) * | 1987-12-04 | 1990-06-12 | Takeda Chemical Industries, Ltd. | Antibiotic composition |
| AU615966B2 (en) * | 1987-12-04 | 1991-10-17 | Takeda Chemical Industries Ltd. | Crystals of cephem hydrochloride |
| DE69106902T2 (de) * | 1990-03-01 | 1995-07-06 | Takeda Chemical Industries Ltd | Imidazopyridazine, ihre Herstellung und Verwendung. |
| TW526202B (en) | 1998-11-27 | 2003-04-01 | Shionogi & Amp Co | Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity |
| ATE449775T1 (de) * | 2003-04-30 | 2009-12-15 | Trine Pharmaceuticals Inc | Carbacephem beta-lactam-antibiotika |
| AU2009310959B2 (en) | 2008-10-31 | 2015-05-07 | Shionogi & Co., Ltd. | Cephalosporin having catechol group |
| MX2012011521A (es) | 2010-04-05 | 2013-03-08 | Shionogi & Co | Compuestos cefem que tienen un grupo catecol. |
| TWI547496B (zh) | 2011-10-04 | 2016-09-01 | 葛蘭素集團公司 | 抗菌化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4165430A (en) * | 1976-03-19 | 1979-08-21 | Glaxo Laboratories Limited | Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group |
| EP0062321B1 (en) * | 1981-04-03 | 1989-03-01 | Fujisawa Pharmaceutical Co., Ltd. | New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds |
| DE3336757A1 (de) * | 1983-10-08 | 1985-04-25 | Hoechst Ag, 6230 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
-
1985
- 1985-04-17 NO NO851538A patent/NO165842C/no unknown
- 1985-04-18 DE DE8585104687A patent/DE3586547D1/de not_active Expired - Fee Related
- 1985-04-18 PH PH32153A patent/PH23134A/en unknown
- 1985-04-18 EP EP85104687A patent/EP0160252B1/en not_active Expired - Lifetime
- 1985-04-18 DE DE8585104687T patent/DE3586547T2/de not_active Expired - Lifetime
- 1985-04-22 JP JP60086746A patent/JPH07103130B2/ja not_active Expired - Fee Related
- 1985-04-22 PT PT80328A patent/PT80328B/pt not_active IP Right Cessation
- 1985-04-22 GR GR850965A patent/GR850965B/el unknown
- 1985-04-22 FI FI851592A patent/FI851592L/fi not_active Application Discontinuation
- 1985-04-22 NZ NZ211858A patent/NZ211858A/xx unknown
- 1985-04-22 ES ES542447A patent/ES8606362A1/es not_active Expired
- 1985-04-23 CA CA000479769A patent/CA1283096C/en not_active Expired - Lifetime
- 1985-04-23 AU AU41700/85A patent/AU580995B2/en not_active Ceased
- 1985-04-23 KR KR1019850002737A patent/KR920008945B1/ko not_active IP Right Cessation
- 1985-11-22 ES ES549180A patent/ES8707245A1/es not_active Expired
- 1985-11-26 NO NO85854730A patent/NO167293C/no unknown
-
1986
- 1986-04-03 ES ES553666A patent/ES8706692A1/es not_active Expired
- 1986-10-03 ES ES557129A patent/ES8800950A1/es not_active Expired
-
1991
- 1991-11-16 KR KR1019910020376A patent/KR920008953B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU580995B2 (en) | 1989-02-09 |
| PT80328B (en) | 1987-02-16 |
| CA1283096C (en) | 1991-04-16 |
| ES557129A0 (es) | 1987-12-01 |
| PH23134A (en) | 1989-05-11 |
| KR850007427A (ko) | 1985-12-04 |
| ES542447A0 (es) | 1986-04-01 |
| ES549180A0 (es) | 1987-07-16 |
| NO167293B (no) | 1991-07-15 |
| ES8800950A1 (es) | 1987-12-01 |
| PT80328A (en) | 1985-05-01 |
| NO165842C (no) | 1991-04-17 |
| EP0160252A3 (en) | 1987-01-14 |
| NO851538L (no) | 1985-10-24 |
| NO165842B (no) | 1991-01-07 |
| ES8606362A1 (es) | 1986-04-01 |
| DE3586547T2 (de) | 1993-04-15 |
| AU4170085A (en) | 1985-10-31 |
| GR850965B (no) | 1985-11-25 |
| FI851592A0 (fi) | 1985-04-22 |
| KR920008953B1 (ko) | 1992-10-12 |
| NZ211858A (en) | 1988-08-30 |
| FI851592L (fi) | 1985-10-24 |
| NO167293C (no) | 1991-10-23 |
| EP0160252A2 (en) | 1985-11-06 |
| ES8707245A1 (es) | 1987-07-16 |
| DE3586547A1 (no) | 1993-02-04 |
| EP0160252B1 (en) | 1992-08-26 |
| ES553666A0 (es) | 1987-06-16 |
| ES8706692A1 (es) | 1987-06-16 |
| KR920008945B1 (ko) | 1992-10-12 |
| JPH07103130B2 (ja) | 1995-11-08 |
| JPS60231684A (ja) | 1985-11-18 |
| DE3586547D1 (de) | 1993-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK279780A (da) | 2-formyl-3-hydroxy-phenoxyforbindelser deres fremstilling og anvendelse og mellemprodukter anvendelige ved deres fremstilling | |
| DK306885D0 (da) | Substituerede benzoatestere af 3-hydroxymorphinaner, deres fremstilling og anvendelse | |
| DK457781A (da) | Bicyclooxyhenylurinstoffer deres fremstilling og anvendelse | |
| FI881223A0 (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi | |
| NO803328L (no) | Krystallinske borsilikatmaterialer og fremgangsmaate ved fremstilling derav | |
| NO851524L (no) | Fremgangsmaate for fremstilling av fenetanolamin-forbindelser | |
| ES546360A0 (es) | Procedimiento para la obtencion de poli-hidro piridazo dia- cepinas triacepinas o diazocinas | |
| ZA857081B (en) | Composition for the treatment of allergy | |
| NO854730L (no) | Mellomprodukter for bruk ved fremstilling av antibakterielt virksomme cefem-forbindelser og fremgangsmaate for deres fremstilling | |
| IT1200085B (it) | Procedimento per la preparazione di xantoni e di tioxantoni | |
| NO170924C (no) | Fremgangsmaate for fremstilling av zeolitt l | |
| DK407383A (da) | Diaminopyrimidiner, fremgangsmaader til deres fremstilling, deres anvendelse og mellemprodukter anvendelige ved forbindelsernes fremstilling | |
| TR22145A (tr) | Hidroksi-4-2h-1-benzotiopiron-2-one tuerevleri bunlarin hazirlanmasi ve kullanilmasi | |
| NO169126C (no) | Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin | |
| NO170159C (no) | Fortykningsmiddel og anvendelse av dette | |
| NO851758L (no) | Fremgangsmaate ved fremstilling av isokinolinderivater | |
| DK326085D0 (da) | 4-amino-2-phenylquinoliner, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter | |
| DK169481A (da) | Kobberphthalocyaninpigmenter deres fremstilling og deres anvendelse | |
| NO851059L (no) | Fremgangsmaate for fremstilling av 2-oksindol-1-karboks-amider og mellomprodukter for anvendelse ved fremgangsmaaten. | |
| DK318081A (da) | Kondenserede as-triazinderivater deres fremstilling og anvendelse | |
| NO168581C (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer | |
| BR8502317A (pt) | Aparelho para combinacao de tiras de cadarco de fecho corredico | |
| NO170140C (no) | Fremgangsmaate for overflatebehandling av materialer med plane overflater | |
| NO812937L (no) | Fremgangsmaate ved fremstilling av terapeutisk virksomt n-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid | |
| TR22560A (tr) | Sulfonilguanidinopirimidin tuerevleri |